-
Talking about "hypoglycemia" and "stability": do sulfonylureas make weight gain?
Time of Update: 2022-11-04
Fig. 2 Weight changes of glimepiride and linagliptin at 5 years of follow-upTherefore, the third generation of sulfonylurea hypoglycemic drugs represented by glimepiride bind rapidly to the receptor and can stimulate insulin faster and more effectively.
-
The ancient Black Death still affects the human immune system to this day! Do you know the dark side of genes?
Time of Update: 2022-11-04
Genes that once protected humans from plague are now found to be more susceptible to disease To identify genes that may have protected humans from infection and death during the Black Death, researchers from McMeister University, the University of Chicago, and the Pasteur Institute characterized 206 immune-related genes from ancient DNA extracts from two different European populations before, during, and after the Black Death.
-
Chronic immunotoxicity of immune checkpoint inhibitors
Time of Update: 2022-11-04
Finally, the presence of multiple comorbidities common in cancer patients may further impair the recognition of chronic irAEs. Despite these challenges, however, the persistent clinical response observed in a subset of patients treated with ICIs has allowed some follow-up studies to yield preliminary insights.
-
Endocrinology: Growth hormone may promote aging! The opposite will prolong life
Time of Update: 2022-11-04
The most important role of growth hormone is to regulate growth, however, its presence has both advantages and disadvantages. Growth hormone is found in many tissues of the human body and plays an imp
-
Authoritative interpretation of the 2022 new guide to hyperthyroidism
Time of Update: 2022-11-04
Jing LiDepartment of Endocrinology, The First Affiliated Hospital of China Medical UniversityProfessor Li Jing pointed out: "It should be noted that non-thyroid TSH reduction must be excluded in the diagnosis process, heterophilic TSH antibody interference, high-dose use of glucocorticoids, mental anxiety and other factors may have non-thyroid TSH level reduction, therefore, the diagnosis of subclinical thyrotoxicosis must be differentiated.
-
Human induced pluripotent stem cells differentiate into hypothalamic vasopressin neurons with minimal exogenous signals and partial transformation into a naïve state or treatable central diabetes insipidus
Time of Update: 2022-11-04
Differentiation of human induced pluripotent stem cells into hypothalamic vasopressin neurons with minimal exogenous signals and partial conversion to the naive state.
Differentiation of human induced pluripotent stem cells into hypothalamic vasopressin neurons with minimal exogenous signals and partial conversion to the naive state.
-
Guidelines and evidence in Chinese General Practice: A summary of the best evidence for the management of nail disease in patients with diabetes
Time of Update: 2022-11-04
This study searched for clinical decisions, guidelines and expert consensus related to the management of thyroid disease in diabetic patients, and summarized the best evidence for the management of thyroid disease in diabetic patients through analysis, involving three aspects: assessment content, treatment methods and health education, which can provide evidence-based evidence for medical staff to provide evidence-based evidence for the early assessment and treatment of nail disease in diabetic patients.
-
White-collar workers have many needs to lose weight, but it is not easy to find a doctor and ask for medicine? The one-stop comprehensive diagnosis and treatment platform settled in Yaoying Medical
Time of Update: 2022-11-04
Now, he innovatively combines the clinical experience of tertiary hospitals with the concept of high-quality service, hoping to build such a center at Yaoying Medical to "truly achieve the ultimate communication between doctors and patients, so that obesity and the endocrine and metabolic diseases caused by it can be truly and long-term controlled.
-
The antimalarial drug "hydroxychloroquine" can be used as an adjuvant after "double-drug resistance" in patients with type 2 diabetes! Stable and high safety in reducing glucose!
Time of Update: 2022-11-04
This is a double-blind, placebo-controlled, parallel-group study of 304 participants with type 2 diabetes mellitus (T2DM) with inadequate glycaemic control who were given two oral antidiabetic drugs (glimepiride 4 mg and metformin 500 mg) at baseline, randomly assigned to hydroxychloroquine (HCQ) 200 mg, 300 mg, 400 mg once daily (OD) or placebo.
-
Is diabetes screening important? Not! What matters is early pharmacological intervention!
Time of Update: 2022-11-04
S. Preventive Services Task Force (USPSTF) recommended screening for blood glucose levels in overweight or obese adults ages 40 to 70 as part of a cardiovascular risk assessment.
-
Cardiovasc diabetol: Relationship between the course of diabetes and mortality in hospitalized patients with acute myocardial infarction
Time of Update: 2022-11-04
Recently, a research article was published in Cardiovasc Diabetol, an authoritative journal in the field of cardiometabolic diseases, in which researchers assessed the in-hospital mortality rate of AMI patients based on the status and duration of diabetes in subjects.
-
Cardiovasc diabetol: long-term cardiovascular outcomes of gestational diabetes
Time of Update: 2022-11-04
Recently, Cardiovasc Diabetol, an authoritative journal in the field of cardiovascular and metabolic diseases, published a research article in which researchers aimed to assess whether women with a history of gestational diabetes had an increased risk of long-term overall cardiovascular outcomes.
-
Women quit sugar and quit milk tea after 1 year and become white and younger
Time of Update: 2022-11-04
Forward the reminder!A cup of milk tea, trans fatty acids exceed the standard by 3 times, sugar is equal to about 20 bags of white sugar, fat content is equal to about 6 bags of potato chips.
-
Diabetes Care: Cagliflozin and glimepiride can improve the progression of nonalcoholic fatty liver disease to a small extent!
Time of Update: 2022-11-04
Overall, this study found that topagliflozin and glimepiride improved liver histology and metabolism to a lesser extent in patients with type 2 diabetes and NAFLD, with no significant difference between the two drugs.
-
Recommended reading: Expert consensus on weight management in people with type 2 diabetes
Time of Update: 2022-11-04
Guideline name: Expert consensus on weight management in patients with type 2 diabetesEnglish:Publisher: Department of Endocrinology and Metabolism, Xijing Hospital, Air Force Military Medical Univers
-
Patients with the three highs of "three minus three health, healthy companionship" should pay attention to the screening and early intervention of osteoporosis
Time of Update: 2022-11-01
High blood pressure –Common comorbidities of osteoporosisA study for middle-aged and elderly patients with chronic diseases published in China in 2022 showed that the prevalence of osteoporosis in hypertensive patients was significantly higher than that of ordinary control groups [7].
-
Oral hypoglycemic drugs fail, how to choose insulin to stabilize hypoglycemia?
Time of Update: 2022-11-01
*For medical professionals onlyThe correct selection of hypoglycemic drugs can help diabetics easily control sugar. In the treatment of type 2 diabetes, more and more patients are facing problems such
-
Do you know all the 16 details of gout "drug treatment"?
Time of Update: 2022-11-01
Uric acid-lowering drugs shall not be stopped without authorization Like chronic diseases such as diabetes and high blood pressure, gout patients often need long-term maintenance medication.
Uric acid-lowering drugs shall not be stopped without authorization Like chronic diseases such as diabetes and high blood pressure, gout patients often need long-term maintenance medication.
-
Dapagliflozin new indication approved! Can be used for the treatment of chronic kidney disease
Time of Update: 2022-11-01
39% reduction in relative risk for primary cardiorenal endpoints and 31% relative risk of all-cause mortality The DAPA-CKD Phase III trial showed that dapagliflozin reduced the relative risk of the primary endpoint of deterioration of renal function, end-stage renal disease, cardiovascular disease, or death from cardiovascular disease by 39% compared with placebo in patients with elevated stage 2 to 4 urine albumin (absolute risk reduction [ARR] = 5.
-
Can injections that are only given once a week really reduce blood sugar and lose weight?
Time of Update: 2022-11-01
Open the Lilac Doctor app and search for "orlistat"Check out the more detailed encyclopedia answer nowIn addition to lowering blood sugar, this hypoglycemic injection can alsodelay gastric emptyingsuppress appetite, and some diabetics who receive treatment will experienceweight loss.